Results 81 to 90 of about 2,230,889 (288)
Hepatorenal syndrome in decompensated portal hypertension
Medičnì PerspektiviHepatorenal syndrome is the development of kidney failure in patients with decompensated chronic diseases with portal hypertension. This study aimed to search for optimal methods of early diagnostics, therapeutic approaches and establishment of ...
M.I. Tutchenko +5 more
doaj +1 more source
Predictors of hepatorenal syndrome in alcoholic liver cirrhosis
Biomedical Papers, 2015 Background: Alcoholic liver disease is a major cause of liver cirrhosis and the hepatorenal syndrome is a serious complication. Risk factors for hepatorenal syndrome (HRS) in alcoholic liver cirrhosis are not entirely explored.
Martin Janicko +3 more
doaj +1 more source
Nephrogenic systemic fibrosis risk and liver disease. [PDF]
, 2014 Objective. Evaluate the incidence of nephrogenic systemic fibrosis (NSF) in patients with liver disease in the peritransplant period. Materials and Methods. This IRB approved study retrospectively reviewed patients requiring transplantation for cirrhosis,
Chow, Daniel S +6 more
core +3 more sources
Alimentary Pharmacology and Therapeutics, 2020 Hepatorenal syndrome and acute kidney injury are common complications of decompensated cirrhosis, and terlipressin is recommended as first‐line vasoconstrictor therapy. However, data on its use outside of clinical trials are lacking.
K. Moore +12 more
semanticscholar +1 more source
End‐stage liver disease: Management of hepatorenal syndrome
Liver international (Print), 2021 Hepatorenal syndrome (HRS) is a serious complication of cirrhosis with high morbidity and mortality rates. Recently, the definition of HRS type 1 has been updated and is now called HRS‐AKI.
E. Mauro +2 more
semanticscholar +1 more source
Egyptian Liver Journal, 2022 Background Hepatorenal syndrome is still a diagnosis of exclusion despite new classification. Aims To validate the accuracy of urinary neutrophil gelatinase-associated lipocalin, interleukin-18, and kidney injury molecule-1 in the new diagnostic criteria
Mona Abd El-Rahman Abu El-Makarem +4 more
doaj +1 more source
Beta-blokers in patients with cirrhosis and infection: don't blame too soon. [PDF]
, 2015 We found that PPI-users had a higher rate and BBs-users a lower rate of infections. The lower infection rate and better prognosis of BB-users can not be attributed, as suggested by Schiavon et al., to a higher proportion of variceal bleeding in this ...
LUCIDI, CRISTINA +3 more
core +1 more source
Journal of V. N. Karazin Kharkiv National University: Series Medicine, 2022 Introduction. Enteral insufficiency syndrome accompanies the development of many acute diseases of the abdominal cavity. According to statistics, as a result of advanced and multi-organ surgery in oncosurgery for 2019–2020, enteral insufficiency was a ...
Oleksii Pavliuchenko +6 more
doaj +1 more source
Hemodynamic Evaluation of Nonselective \u3b2-Blockers in Patients with Cirrhosis and Refractory Ascites [PDF]
, 2018 BACKGROUND:Nonselective \u3b2-blockers (NSBB) have been associated with increased incidence of paracentesis-induced circulatory dysfunction (PICD) and reduced survival in patients with cirrhosis and refractory ascites.
Angeli, Paolo +10 more
core +2 more sources
Liver Kidney Crosstalk: Hepatorenal Syndrome
World Journal of Hepatology, 2021 The dying liver causes the suffocation of the kidneys, which is a simplified way of describing the pathophysiology of hepatorenal syndrome (HRS). HRS is characterized by reversible functional renal impairment due to reduced blood supply and glomerular ...
Mahmoud Nassar +10 more
semanticscholar +1 more source